Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Development Runs Completed

LONDON, UK / ACCESSWIRE / November 18, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is pleased to announce the successful completion of its second and …